A Chewing Study of Abuse-Deterrent Tablets Containing Polyethylene Oxide Using a Robotic Simulator
Abuse-deterrent formulations (ADFs) refer to formulation technologies aiming to deter the abuse of prescription drugs by making the dosage forms difficult to manipulate or extract the opioids. Assessments are required to evaluate the performance of the drugs through different routes including inject...
Saved in:
Published in | AAPS PharmSciTech Vol. 24; no. 8; p. 245 |
---|---|
Main Authors | , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Cham
Springer International Publishing
29.11.2023
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Abuse-deterrent formulations (ADFs) refer to formulation technologies aiming to deter the abuse of prescription drugs by making the dosage forms difficult to manipulate or extract the opioids. Assessments are required to evaluate the performance of the drugs through different routes including injection, ingestion, and insufflation and also when the drugs are manipulated. Chewing is the easiest and most convenient way to manipulate the drugs and deserves investigation. Chewing is one of the most complex bioprocesses, where the ingested materials are subject to periodic tooth crushing, mixed through the tongue, and lubricated and softened by the saliva. Inter- and intra-subject variations in chewing patterns may result in different chewing performances. The purpose of this study is to use a chewing simulator to assess the deterrent properties of tablets made of polyethylene oxide (PEO). The simulator can mimic human molar grinding with variable chewing parameters including molar trajectory, chewing frequency, and saliva flow rate. To investigate the effects of these parameters, the sizes of the chewed tablet particles and the chewing force were measured to evaluate the chewing performance. Thirty-four out of forty tablets were broken into pieces. The results suggested that the simulator can chew the tablets into smaller particles and that the molar trajectory and saliva flow rate had significant effect on reducing the size of the particles by analysis of variance (ANOVA) while the effect of chewing frequency was not clear. Additionally, chewing force can work as an indicator of the chewing performance. |
---|---|
AbstractList | Abuse-deterrent formulations (ADFs) refer to formulation technologies aiming to deter the abuse of prescription drugs by making the dosage forms difficult to manipulate or extract the opioids. Assessments are required to evaluate the performance of the drugs through different routes including injection, ingestion, and insufflation and also when the drugs are manipulated. Chewing is the easiest and most convenient way to manipulate the drugs and deserves investigation. Chewing is one of the most complex bioprocesses, where the ingested materials are subject to periodic tooth crushing, mixed through the tongue, and lubricated and softened by the saliva. Inter- and intra-subject variations in chewing patterns may result in different chewing performances. The purpose of this study is to use a chewing simulator to assess the deterrent properties of tablets made of polyethylene oxide (PEO). The simulator can mimic human molar grinding with variable chewing parameters including molar trajectory, chewing frequency, and saliva flow rate. To investigate the effects of these parameters, the sizes of the chewed tablet particles and the chewing force were measured to evaluate the chewing performance. Thirty-four out of forty tablets were broken into pieces. The results suggested that the simulator can chew the tablets into smaller particles and that the molar trajectory and saliva flow rate had significant effect on reducing the size of the particles by analysis of variance (ANOVA) while the effect of chewing frequency was not clear. Additionally, chewing force can work as an indicator of the chewing performance. Abuse-deterrent formulations (ADFs) refer to formulation technologies aiming to deter the abuse of prescription drugs by making the dosage forms difficult to manipulate or extract the opioids. Assessments are required to evaluate the performance of the drugs through different routes including injection, ingestion, and insufflation and also when the drugs are manipulated. Chewing is the easiest and most convenient way to manipulate the drugs and deserves investigation. Chewing is one of the most complex bioprocesses, where the ingested materials are subject to periodic tooth crushing, mixed through the tongue, and lubricated and softened by the saliva. Inter- and intra-subject variations in chewing patterns may result in different chewing performances. The purpose of this study is to use a chewing simulator to assess the deterrent properties of tablets made of polyethylene oxide (PEO). The simulator can mimic human molar grinding with variable chewing parameters including molar trajectory, chewing frequency, and saliva flow rate. To investigate the effects of these parameters, the sizes of the chewed tablet particles and the chewing force were measured to evaluate the chewing performance. Thirty-four out of forty tablets were broken into pieces. The results suggested that the simulator can chew the tablets into smaller particles and that the molar trajectory and saliva flow rate had significant effect on reducing the size of the particles by analysis of variance (ANOVA) while the effect of chewing frequency was not clear. Additionally, chewing force can work as an indicator of the chewing performance.Abuse-deterrent formulations (ADFs) refer to formulation technologies aiming to deter the abuse of prescription drugs by making the dosage forms difficult to manipulate or extract the opioids. Assessments are required to evaluate the performance of the drugs through different routes including injection, ingestion, and insufflation and also when the drugs are manipulated. Chewing is the easiest and most convenient way to manipulate the drugs and deserves investigation. Chewing is one of the most complex bioprocesses, where the ingested materials are subject to periodic tooth crushing, mixed through the tongue, and lubricated and softened by the saliva. Inter- and intra-subject variations in chewing patterns may result in different chewing performances. The purpose of this study is to use a chewing simulator to assess the deterrent properties of tablets made of polyethylene oxide (PEO). The simulator can mimic human molar grinding with variable chewing parameters including molar trajectory, chewing frequency, and saliva flow rate. To investigate the effects of these parameters, the sizes of the chewed tablet particles and the chewing force were measured to evaluate the chewing performance. Thirty-four out of forty tablets were broken into pieces. The results suggested that the simulator can chew the tablets into smaller particles and that the molar trajectory and saliva flow rate had significant effect on reducing the size of the particles by analysis of variance (ANOVA) while the effect of chewing frequency was not clear. Additionally, chewing force can work as an indicator of the chewing performance. |
ArticleNumber | 245 |
Author | Chen, Bangxiang Dhupia, Jaspreet Costello, Mark Raofi, Saeid Tian, Li Boyce, Heather Xu, Weiliang Morgenstern, Marco P. Zhang, Feng Sun, Wei-Jhe |
Author_xml | – sequence: 1 givenname: Bangxiang orcidid: 0000-0002-7508-8743 surname: Chen fullname: Chen, Bangxiang email: bangxiang.chen@auckland.ac.nz organization: Department of Mechanical and Mechatronics Engineering, The University of Auckland – sequence: 2 givenname: Feng surname: Zhang fullname: Zhang, Feng organization: College of Pharmacy, The University of Texas at Austin – sequence: 3 givenname: Jaspreet surname: Dhupia fullname: Dhupia, Jaspreet organization: Department of Mechanical and Mechatronics Engineering, The University of Auckland – sequence: 4 givenname: Marco P. surname: Morgenstern fullname: Morgenstern, Marco P. organization: Food Materials & Structures, Plant & Food Research Ltd – sequence: 5 givenname: Mark surname: Costello fullname: Costello, Mark organization: College of Pharmacy, The University of Texas at Austin – sequence: 6 givenname: Heather surname: Boyce fullname: Boyce, Heather organization: Office of Research and Standards, Office of Generic Drugs, Center for Drug Evaluation and Research, US Food and Drug Administration – sequence: 7 givenname: Wei-Jhe surname: Sun fullname: Sun, Wei-Jhe organization: Office of Research and Standards, Office of Generic Drugs, Center for Drug Evaluation and Research, US Food and Drug Administration – sequence: 8 givenname: Saeid surname: Raofi fullname: Raofi, Saeid organization: Office of Research and Standards, Office of Generic Drugs, Center for Drug Evaluation and Research, US Food and Drug Administration – sequence: 9 givenname: Li surname: Tian fullname: Tian, Li organization: Office of Testing and Research, Office of Pharmaceutical Quality, Center for Drug Evaluation and Research, US Food and Drug Administration – sequence: 10 givenname: Weiliang surname: Xu fullname: Xu, Weiliang organization: Department of Mechanical and Mechatronics Engineering, The University of Auckland |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/38030835$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kU1LxDAURYMo6qh_wIVk6aaaj6ZNlsP4CYLi6Dqk7atGOokmKTr_3oyjIC5cPBJ457zFvRO06bwDhA4pOaGMyNNIGStVQRjPU5OqEBtolwpOCqU42_z130GTGF9IJqni22iHS8KJ5GIXNVM8e4Z3657wPI3dEvseT5sxQnEGCUIAl_CDaQZIEc-8S8a6FXvnhyWk5-UADvDth-0AP8bVwuB73_hkWzy3i3EwyYd9tNWbIcLB97uHHi_OH2ZXxc3t5fVselO0vKxTITn0Vdnxqs_TdYJJaEzFiFCMqF6yWklCStaIui-73jDR1IxQowQQxSvgfA8dr---Bv82Qkx6YWMLw2Ac-DFqJpWoKZWqyujRNzo2C-j0a7ALE5b6J5cMyDXQBh9jgF63NplkcwLB2EFTolcV6HUFOgervyrQK5X9UX-u_yvxtRQz7J4g6Bc_Bpfj-s_6BAojl58 |
CitedBy_id | crossref_primary_10_1109_ACCESS_2025_3539623 |
Cites_doi | 10.2165/11635860-000000000-00000 10.1208/s12249-019-1528-3 10.1016/j.jddst.2023.104450 10.1111/j.1365-2842.2011.02204.x 10.1080/096374800426948 10.1208/s12249-020-01646-8 10.1093/pm/pnw208 10.1016/j.jfoodeng.2007.02.008 10.1016/j.ijpharm.2022.122557 10.1111/joor.12149 10.1097/ALN.0000000000002031 10.1007/s12247-023-09731-8 10.1016/j.mechmachtheory.2008.06.003 10.1016/j.jbiomech.2010.03.002 10.1208/s12249-017-0947-2 10.1208/s12249-019-1452-6 10.1007/s40122-016-0062-1 10.1034/j.1601-0825.2002.02851.x 10.1111/pme.12834 10.1016/j.ijpharm.2016.12.015 10.1016/j.ijpharm.2022.122151 10.1016/j.ijpharm.2016.06.012 10.1016/j.ijpharm.2016.01.031 10.1016/j.chroma.2023.464186 10.36076/ppj/2017.7.E1003 10.1016/j.physbeh.2006.05.012 10.1016/j.ijpharm.2022.122486 10.1111/cts.13053 10.1177/0269216317717192 10.1080/03639045.2018.1504965 10.1016/j.ijpharm.2019.03.017 10.3390/pharmaceutics3010073 10.1007/s00221-001-0916-5 10.1016/j.xphs.2019.12.003 10.1115/1.4052379 10.1208/s12249-019-1565-y 10.1208/s12249-019-1594-6 10.1016/j.tifs.2013.10.005 10.1016/j.ifset.2020.102524 10.1016/j.ijpharm.2022.122430 10.1007/s00784-014-1266-6 10.1016/j.foodhyd.2007.11.013 10.1038/nmeth.2089 10.1016/j.ijpharm.2019.118602 10.1111/j.1365-2842.2010.02197.x 10.1016/j.cofs.2016.03.006 10.2319/061109-333.1 10.1016/j.ajodo.2009.07.025 10.1208/s12249-021-02169-6 10.1001/jamapsychiatry.2014.3043 10.1007/s10266-016-0292-z |
ContentType | Journal Article |
Copyright | The Author(s), under exclusive licence to American Association of Pharmaceutical Scientists 2023. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. 2023. The Author(s), under exclusive licence to American Association of Pharmaceutical Scientists. |
Copyright_xml | – notice: The Author(s), under exclusive licence to American Association of Pharmaceutical Scientists 2023. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. – notice: 2023. The Author(s), under exclusive licence to American Association of Pharmaceutical Scientists. |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 |
DOI | 10.1208/s12249-023-02706-5 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Pharmacy, Therapeutics, & Pharmacology |
EISSN | 1530-9932 |
ExternalDocumentID | 38030835 10_1208_s12249_023_02706_5 |
Genre | Journal Article |
GroupedDBID | --- -56 -5G -BR -EM -~C .86 .VR 06C 06D 0R~ 0VY 1N0 203 23M 29~ 2J2 2JN 2JY 2KG 2KM 2LR 2~H 30V 406 408 40D 40E 53G 5GY 5VS 67N 6J9 6NX 875 8TC 8UJ 95- 95. 95~ 96X AAAVM AABHQ AACDK AAHNG AAIAL AAJBT AAJKR AAKDD AANZL AARTL AASML AATNV AATVU AAUYE AAWCG AAYIU AAYQN AAYTO AAYZH ABAKF ABDZT ABECU ABFTV ABHLI ABHQN ABJNI ABJOX ABKCH ABMNI ABMQK ABNWP ABPLI ABQBU ABSXP ABTEG ABTHY ABTKH ABTMW ABWNU ABXPI ACAOD ACDTI ACGFO ACGFS ACHSB ACKNC ACMDZ ACMJI ACMLO ACOKC ACOMO ACPIV ACREN ACSNA ACZOJ ADBBV ADHHG ADHIR ADINQ ADKNI ADKPE ADRFC ADURQ ADYFF ADYOE ADZKW AEFQL AEGAL AEGNC AEJHL AEJRE AEMSY AENEX AEOHA AEPYU AESKC AETLH AEVLU AEXYK AFBBN AFLOW AFQWF AFWTZ AFYQB AFZKB AGAYW AGDGC AGMZJ AGQEE AGQMX AGRTI AGWZB AGYKE AHAVH AHBYD AHKAY AHYZX AIAKS AIGIU AIIXL AILAN AITGF AJRNO AJZVZ AKMHD ALMA_UNASSIGNED_HOLDINGS ALWAN AMKLP AMTXH AMXSW AMYLF AMYQR AOCGG ARMRJ AXYYD B-. BA0 BAWUL BGNMA CS3 CSCUP DDRTE DIK DNIVK DPUIP E3Z EBLON EBS EIOEI EMOBN ESBYG F5P FERAY FFXSO FIGPU FNLPD FRRFC FWDCC G-Y G-Z GGCAI GGRSB GJIRD GNWQR GQ6 GQ7 HG6 HH5 HMJXF HRMNR IJ- IKXTQ IWAJR IXC IXD I~X I~Z J-C J0Z JBSCW JZLTJ KOV KPH LGEZI LLZTM LOTEE M4Y MA- NADUK NPVJJ NQJWS NU0 NXXTH O93 O9I O9J OK1 P2P PF0 PT4 QOR QOS R89 R9I ROL RPM RPX RSV S16 S27 S3A S3B SAP SBL SHX SISQX SJYHP SNE SNPRN SNX SOHCF SOJ SPISZ SRMVM SSLCW SSXJD STPWE SZN T13 TR2 TSG TSV TUC U2A U9L UG4 UOJIU UTJUX UZXMN VC2 VFIZW W48 WK8 XSB YLTOR Z45 Z7U Z7V Z7W Z7X Z81 Z87 ZMTXR ZOVNA ~A9 AAPKM AAYXX ABBRH ABDBE ABFSG ACMFV ACSTC AEZWR AFDZB AFHIU AFOHR AHPBZ AHWEU AIXLP ATHPR AYFIA CITATION ABRTQ CGR CUY CVF ECM EIF NPM 7X8 |
ID | FETCH-LOGICAL-c347t-83ef64d36fd36dd528eba62059209f827980042b57f4dfa25b7201a95e0936e33 |
IEDL.DBID | U2A |
ISSN | 1530-9932 |
IngestDate | Mon Jul 21 10:55:47 EDT 2025 Mon Jul 21 06:04:36 EDT 2025 Tue Jul 01 01:55:55 EDT 2025 Thu Apr 24 23:03:43 EDT 2025 Fri Feb 21 02:40:28 EST 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 8 |
Keywords | abuse-deterrent formulation physical barrier manipulation simulated chewing opioids in vitro manipulation |
Language | English |
License | 2023. The Author(s), under exclusive licence to American Association of Pharmaceutical Scientists. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c347t-83ef64d36fd36dd528eba62059209f827980042b57f4dfa25b7201a95e0936e33 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ORCID | 0000-0002-7508-8743 |
PMID | 38030835 |
PQID | 2895711896 |
PQPubID | 23479 |
ParticipantIDs | proquest_miscellaneous_2895711896 pubmed_primary_38030835 crossref_citationtrail_10_1208_s12249_023_02706_5 crossref_primary_10_1208_s12249_023_02706_5 springer_journals_10_1208_s12249_023_02706_5 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2023-11-29 |
PublicationDateYYYYMMDD | 2023-11-29 |
PublicationDate_xml | – month: 11 year: 2023 text: 2023-11-29 day: 29 |
PublicationDecade | 2020 |
PublicationPlace | Cham |
PublicationPlace_xml | – name: Cham – name: United States |
PublicationSubtitle | An Official Journal of the American Association of Pharmaceutical Scientists |
PublicationTitle | AAPS PharmSciTech |
PublicationTitleAbbrev | AAPS PharmSciTech |
PublicationTitleAlternate | AAPS PharmSciTech |
PublicationYear | 2023 |
Publisher | Springer International Publishing |
Publisher_xml | – name: Springer International Publishing |
References | Salem, Smith, Byrn (CR16) 2023; 84 Boyce, Dave, Scoggins, Gurvich, Smith, Byrn (CR49) 2020; 21 Chen (CR31) 2009; 23 Hoebler, Devaux, Karinthi, Belleville, Barry (CR40) 2000; 51 Litman, Pagán, Cicero (CR2) 2018; 128 Smith, Qu, Zheng, Baek, Gao, Buehler (CR18) 2023; 632 Harris, Cipriano, Colucci, Kapil, Geoffroy, Hopyan (CR28) 2017; 18 CR30 Woda, Mishellany-Dutour, Batier, François, Meunier, Reynaud (CR46) 2010; 43 Gudin (CR10) 2016; 5 Barakh Ali, Dharani, Afrooz, Mohamed, Cook, Khan (CR7) 2020; 21 Komagamine, Kanazawa, Minakuchi, Uchida, Sasaki (CR34) 2011; 38 Hemmingsen, Haahr, Gunnergaard, Cardot (CR6) 2011; 3 Komino, Shiga (CR35) 2017; 105 Externbrink, Sharan, Sun, Jiang, Keire, Xu (CR29) 2019; 561 Dharani, Barakh Ali, Afrooz, Mohamed, Cook, Khan (CR9) 2020; 109 Xu, Bronlund, Potgieter, Foster, Röhrle, Pullan (CR32) 2008; 43 Sohn, Choi (CR12) 2023 Hsu, Yang, Pavuluri, Abraham, Naraharisetti, Ashraf (CR26) 2019; 20 Bannwarth (CR1) 2012; 72 Lepley, Throckmorton, Parker, Buschang (CR42) 2010; 80 Chen, Dhupia, Morgenstern, Bronlund, Xu (CR47) 2022; 14 Feng, Wu, Balajee, Leissa, Ashraf, Xu (CR21) 2023; 631 van der Bilt (CR36) 2011; 38 Salles, Tarrega, Mielle, Maratray, Gorria, Liaboeuf (CR45) 2007; 82 Rezaei, Meruva, Donovan (CR4) 2021; 23 Xu, Gupta, Al-Ghabeish, Calderon, Khan (CR20) 2016; 500 Eberhard, Eberhard, Schneider, Schneider, Eiffler, Eiffler (CR41) 2015; 19 Vasiukhina, Gad, Wellington, Wilmes, Yeo, Solorio (CR13) 2022; 626 Panda, Chen, Benjamin (CR54) 2020; 66 Lepley, Throckmorton, Ceen, Buschang (CR39) 2011; 139 Meullenet, Gandhapuneni (CR44) 2006; 89 CR19 CR14 Qu, Smith, Feng, Wang, Pinto, Xu (CR17) 2023; 1705 Meruva, Donovan (CR48) 2019; 21 CR52 Tocce, Bishop, Balwinski, Watson, Lapham, Hewlett (CR51) 2019; 21 Peyron, Woda (CR55) 2016; 9 Maincent, Zhang (CR8) 2016; 510 Raofi, Kinjo, Sun, Li, Boyce, Natarajan (CR25) 2021; 14 Pedersen, Bardow, Jensen, Nauntofte (CR38) 2002; 8 Morell, Hernando, Fiszman (CR43) 2013; 35 Boyce, Smith, Byrn, Saluja, Qu, Gurvich (CR22) 2018; 19 Schneider, Rasband, Eliceiri (CR53) 2012; 9 Cicero, Ellis (CR3) 2015; 72 Rahman, Zidan, Korang-Yeboah, Yang, Siddiqui, Shakleya (CR5) 2017; 517 Peyron, Lassauzay, Woda (CR33) 2002; 142 Boyce, Ibrahim, Hoag (CR50) 2018; 44 Chen (CR23) 2017; 7 McCulloch, Sattar, Henderson, Lane, Bluebond-Langner (CR11) 2018; 32 Gudin, Levy-Cooperman, Kopecky, Fleming (CR24) 2015; 16 Kuninori, Tomonari, Uehara, Kitashima, Yagi, Miyawaki (CR37) 2014; 41 Ahmad, Omidian (CR27) 2019; 569 Kibria, Bandaranayake, Zheng, Lee, Cruz (CR15) 2023; 631 S Meruva (2706_CR48) 2019; 21 S Salem (2706_CR16) 2023; 84 HJ Boyce (2706_CR49) 2020; 21 J Gudin (2706_CR24) 2015; 16 SF Barakh Ali (2706_CR7) 2020; 21 WC Smith (2706_CR18) 2023; 632 C Lepley (2706_CR42) 2010; 80 X Xu (2706_CR20) 2016; 500 H Chen (2706_CR23) 2017; 7 L Rezaei (2706_CR4) 2021; 23 L Eberhard (2706_CR41) 2015; 19 HJ Boyce (2706_CR50) 2018; 44 2706_CR30 W Xu (2706_CR32) 2008; 43 G Kibria (2706_CR15) 2023; 631 T Kuninori (2706_CR37) 2014; 41 S Raofi (2706_CR25) 2021; 14 P Morell (2706_CR43) 2013; 35 MA Peyron (2706_CR33) 2002; 142 CR Lepley (2706_CR39) 2011; 139 A Vasiukhina (2706_CR13) 2022; 626 A Woda (2706_CR46) 2010; 43 A Pedersen (2706_CR38) 2002; 8 TJ Cicero (2706_CR3) 2015; 72 H Boyce (2706_CR22) 2018; 19 E Tocce (2706_CR51) 2019; 21 A Externbrink (2706_CR29) 2019; 561 R Litman (2706_CR2) 2018; 128 JS Sohn (2706_CR12) 2023 H Hsu (2706_CR26) 2019; 20 SC Harris (2706_CR28) 2017; 18 M Komino (2706_CR35) 2017; 105 J Chen (2706_CR31) 2009; 23 R McCulloch (2706_CR11) 2018; 32 B Chen (2706_CR47) 2022; 14 A van der Bilt (2706_CR36) 2011; 38 X Feng (2706_CR21) 2023; 631 B Bannwarth (2706_CR1) 2012; 72 2706_CR19 C Salles (2706_CR45) 2007; 82 2706_CR52 S Panda (2706_CR54) 2020; 66 J Maincent (2706_CR8) 2016; 510 2706_CR14 M Peyron (2706_CR55) 2016; 9 H Qu (2706_CR17) 2023; 1705 Y Komagamine (2706_CR34) 2011; 38 PH Hemmingsen (2706_CR6) 2011; 3 J Gudin (2706_CR10) 2016; 5 M-F Hoebler (2706_CR40) 2000; 51 CA Schneider (2706_CR53) 2012; 9 S Dharani (2706_CR9) 2020; 109 Z Rahman (2706_CR5) 2017; 517 R Ahmad (2706_CR27) 2019; 569 J Meullenet (2706_CR44) 2006; 89 |
References_xml | – volume: 72 start-page: 1713 year: 2012 end-page: 23 ident: CR1 article-title: Will abuse-deterrent formulations of opioid analgesics be successful in achieving their purpose? publication-title: Drugs. doi: 10.2165/11635860-000000000-00000 – volume: 21 start-page: 2 year: 2019 ident: CR51 article-title: Mechanical characterization of thermally annealed tablets containing polyethylene oxide for abuse deterrence publication-title: AAPS PharmSciTech. doi: 10.1208/s12249-019-1528-3 – volume: 84 start-page: 104450 year: 2023 ident: CR16 article-title: Degradation products of the abuse deterrent agent poly(ethylene) oxide under thermal manipulation conditions publication-title: J Drug Deliv Sci Technol. doi: 10.1016/j.jddst.2023.104450 – volume: 38 start-page: 555 year: 2011 end-page: 63 ident: CR34 article-title: Association between masticatory performance using a colour-changeable chewing gum and jaw movement publication-title: J Oral Rehabil. doi: 10.1111/j.1365-2842.2011.02204.x – volume: 51 start-page: 353 year: 2000 end-page: 66 ident: CR40 article-title: Particle size of solid food after human mastication and in vitro simulation of oral breakdown publication-title: Int J Food Sci Nutr. doi: 10.1080/096374800426948 – volume: 21 start-page: 99 year: 2020 ident: CR7 article-title: Development of abuse-deterrent formulations using sucrose acetate isobutyrate publication-title: AAPS PharmSciTech. doi: 10.1208/s12249-020-01646-8 – volume: 18 start-page: 1278 year: 2017 end-page: 91 ident: CR28 article-title: Oral abuse potential, pharmacokinetics, and safety of once-daily, single-entity, extended-release hydrocodone (HYD) in recreational opioid users publication-title: Pain Med. doi: 10.1093/pm/pnw208 – volume: 82 start-page: 189 year: 2007 end-page: 98 ident: CR45 article-title: Development of a chewing simulator for food breakdown and the analysis of in vitro flavor compound release in a mouth environment publication-title: J Food Eng. doi: 10.1016/j.jfoodeng.2007.02.008 – volume: 632 start-page: 122557 year: 2023 ident: CR18 article-title: Determining critical overlap concentration of polyethylene oxide to support excipient safety assessment of opioid products publication-title: Int J Pharm. doi: 10.1016/j.ijpharm.2022.122557 – volume: 41 start-page: 338 year: 2014 end-page: 45 ident: CR37 article-title: Influence of maximum bite force on jaw movement during gummy jelly mastication publication-title: J Oral Rehabil. doi: 10.1111/joor.12149 – volume: 128 start-page: 1015 year: 2018 end-page: 26 ident: CR2 article-title: Abuse-deterrent opioid formulations publication-title: Anesthesiology. doi: 10.1097/ALN.0000000000002031 – year: 2023 ident: CR12 article-title: Design of abuse-deterrent formulations using various types of thermal deformed starch (TDS) publication-title: J Pharm Innov. doi: 10.1007/s12247-023-09731-8 – volume: 43 start-page: 1353 year: 2008 end-page: 75 ident: CR32 article-title: Review of the human masticatory system and masticatory robotics publication-title: Mech Mach Theory. doi: 10.1016/j.mechmachtheory.2008.06.003 – volume: 43 start-page: 1667 year: 2010 end-page: 73 ident: CR46 article-title: Development and validation of a mastication simulator publication-title: J Biomech. doi: 10.1016/j.jbiomech.2010.03.002 – volume: 19 start-page: 1744 year: 2018 end-page: 57 ident: CR22 article-title: In vitro assessment of nasal insufflation of comminuted drug products designed as abuse deterrent using the vertical diffusion cell publication-title: AAPS PharmSciTech. doi: 10.1208/s12249-017-0947-2 – volume: 20 start-page: 232 year: 2019 ident: CR26 article-title: Effect of formulation variables on the nasal permeability and stability of naloxone intranasal formulations publication-title: AAPS PharmSciTech. doi: 10.1208/s12249-019-1452-6 – ident: CR19 – volume: 5 start-page: 171 year: 2016 end-page: 86 ident: CR10 article-title: Oxycodone DETERx®: a novel abuse-deterrent, extended-release analgesic option for the treatment of patients with chronic pain publication-title: Pain Ther. doi: 10.1007/s40122-016-0062-1 – volume: 8 start-page: 117 year: 2002 end-page: 29 ident: CR38 article-title: Saliva and gastrointestinal functions of taste, mastication, swallowing and digestion publication-title: Oral Dis. doi: 10.1034/j.1601-0825.2002.02851.x – volume: 16 start-page: 2142 year: 2015 end-page: 51 ident: CR24 article-title: Comparing the effect of tampering on the oral pharmacokinetic profiles of two extended-release oxycodone formulations with abuse-deterrent properties publication-title: Pain Med. doi: 10.1111/pme.12834 – volume: 517 start-page: 303 year: 2017 end-page: 11 ident: CR5 article-title: Effects of excipients and curing process on the abuse deterrent properties of directly compressed tablets publication-title: Int J Pharm. doi: 10.1016/j.ijpharm.2016.12.015 – volume: 626 start-page: 122151 year: 2022 ident: CR13 article-title: PLA-PCL microsphere formulation to deter abuse of prescription opioids by smoking publication-title: Int J Pharm. doi: 10.1016/j.ijpharm.2022.122151 – volume: 510 start-page: 57 year: 2016 end-page: 72 ident: CR8 article-title: Recent advances in abuse-deterrent technologies for the delivery of opioids publication-title: Int J Pharm. doi: 10.1016/j.ijpharm.2016.06.012 – volume: 500 start-page: 255 year: 2016 end-page: 67 ident: CR20 article-title: Risk based in vitro performance assessment of extended release abuse deterrent formulations publication-title: Int J Pharm. doi: 10.1016/j.ijpharm.2016.01.031 – volume: 1705 start-page: 464186 year: 2023 ident: CR17 article-title: Asymmetrical flow field flow fractionation for molar mass characterization of polyethylene oxide in abuse-deterrent formulations publication-title: J Chromatogr A. doi: 10.1016/j.chroma.2023.464186 – volume: 7 start-page: 1003 year: 2017 end-page: 23 ident: CR23 article-title: Current impact and application of abuse-deterrent opioid formulations in clinical practice publication-title: Pain Physician. doi: 10.36076/ppj/2017.7.E1003 – volume: 89 start-page: 39 year: 2006 end-page: 43 ident: CR44 article-title: Development of the BITE Master II and its application to the study of cheese hardness publication-title: Physiol Behav. doi: 10.1016/j.physbeh.2006.05.012 – volume: 631 start-page: 122486 year: 2023 ident: CR21 article-title: Understanding syringeability and injectability of high molecular weight PEO solution through time-dependent force-distance profiles publication-title: Int J Pharm. doi: 10.1016/j.ijpharm.2022.122486 – volume: 14 start-page: 1977 year: 2021 end-page: 87 ident: CR25 article-title: Particle size affects pharmacokinetics of milled oxycodone hydrochloride tablet products following nasal insufflation in nondependent, recreational opioid users publication-title: Clin Transl Sci. doi: 10.1111/cts.13053 – volume: 32 start-page: 554 year: 2018 end-page: 8 ident: CR11 article-title: Use of buccal morphine in the management of pain in children with life-limiting conditions: results of a laboratory study publication-title: Palliat Med. doi: 10.1177/0269216317717192 – volume: 44 start-page: 1885 year: 2018 end-page: 94 ident: CR50 article-title: Physical barrier type abuse-deterrent formulations: monitoring sintering-induced microstructural changes in polyethylene oxide placebo tablets by near infrared spectroscopy (NIRS) publication-title: Drug Dev Ind Pharm. doi: 10.1080/03639045.2018.1504965 – volume: 561 start-page: 305 year: 2019 end-page: 13 ident: CR29 article-title: An in vitro approach for evaluating the oral abuse deterrence of solid oral extended-release opioids with properties intended to deter abuse via chewing publication-title: Int J Pharm. doi: 10.1016/j.ijpharm.2019.03.017 – volume: 3 start-page: 73 year: 2011 end-page: 87 ident: CR6 article-title: development of a new type of prolonged release hydrocodone formulation based on Egalet® ADPREM technology using in vivo–in vitro correlation publication-title: Pharmaceutics. doi: 10.3390/pharmaceutics3010073 – ident: CR14 – volume: 142 start-page: 41 year: 2002 end-page: 51 ident: CR33 article-title: Effects of increased hardness on jaw movement and muscle activity during chewing of visco-elastic model foods publication-title: Exp Brain Res. doi: 10.1007/s00221-001-0916-5 – volume: 109 start-page: 1338 year: 2020 end-page: 46 ident: CR9 article-title: Development of methamphetamine abuse–deterrent formulations using sucrose acetate isobutyrate publication-title: J Pharm Sci. doi: 10.1016/j.xphs.2019.12.003 – ident: CR30 – volume: 14 start-page: 021012 year: 2022 ident: CR47 article-title: Development of a biomimetic masticating robot for food texture analysis publication-title: J Mech Robot. doi: 10.1115/1.4052379 – volume: 21 start-page: 28 year: 2019 ident: CR48 article-title: Polyethylene oxide (PEO) molecular weight effects on abuse-deterrent properties of matrix tablets publication-title: AAPS PharmSciTech. doi: 10.1208/s12249-019-1565-y – volume: 21 start-page: 86 year: 2020 ident: CR49 article-title: Physical barrier type abuse-deterrent formulations: mechanistic understanding of sintering-induced microstructural changes in polyethylene oxide placebo tablets publication-title: AAPS PharmSciTech. doi: 10.1208/s12249-019-1594-6 – volume: 35 start-page: 18 year: 2013 ident: CR43 article-title: Understanding the relevance of in-mouth food processing: a review of in vitro techniques publication-title: Trends Food Sci Technol. doi: 10.1016/j.tifs.2013.10.005 – volume: 66 start-page: 102524 year: 2020 ident: CR54 article-title: Development of model mouth for food oral processing studies: present challenges and scopes publication-title: Innov Food Sci Emerg Technol. doi: 10.1016/j.ifset.2020.102524 – volume: 631 start-page: 122430 year: 2023 ident: CR15 article-title: Stability of abuse-deterrent properties of PEO-based abuse-deterrent formulation publication-title: Int J Pharm. doi: 10.1016/j.ijpharm.2022.122430 – volume: 19 start-page: 429 year: 2015 end-page: 36 ident: CR41 article-title: Particle size distributions determined by optical scanning and by sieving in the assessment of masticatory performance of complete denture wearers publication-title: Clin Oral Invest. doi: 10.1007/s00784-014-1266-6 – volume: 23 start-page: 1 year: 2009 end-page: 25 ident: CR31 article-title: Food oral processing—a review publication-title: Food Hydrocoll. doi: 10.1016/j.foodhyd.2007.11.013 – volume: 9 start-page: 671 year: 2012 end-page: 5 ident: CR53 article-title: NIH Image to ImageJ: 25 years of image analysis publication-title: Nat methods. doi: 10.1038/nmeth.2089 – volume: 569 start-page: 118602 year: 2019 ident: CR27 article-title: Development and in vitro evaluation of an abuse-deterrent formulation based on a crosslinked starch derivative publication-title: Int J Pharm. doi: 10.1016/j.ijpharm.2019.118602 – volume: 38 start-page: 754 year: 2011 end-page: 80 ident: CR36 article-title: Assessment of mastication with implications for oral rehabilitation: a review publication-title: J Oral Rehabil. doi: 10.1111/j.1365-2842.2010.02197.x – ident: CR52 – volume: 9 start-page: 21 year: 2016 end-page: 8 ident: CR55 article-title: An update about artificial mastication publication-title: Curr Opin Food Sci. doi: 10.1016/j.cofs.2016.03.006 – volume: 80 start-page: 295 year: 2010 end-page: 301 ident: CR42 article-title: Masticatory performance and chewing cycle kinematics—are they related? publication-title: Angle Orthod. doi: 10.2319/061109-333.1 – volume: 139 start-page: 606 year: 2011 end-page: 13 ident: CR39 article-title: Relative contributions of occlusion, maximum bite force, and chewing cycle kinematics to masticatory performance publication-title: Am J Orthod Dentofacial Orthop. doi: 10.1016/j.ajodo.2009.07.025 – volume: 23 start-page: 38 year: 2021 ident: CR4 article-title: Effect of manufacturing process on the retention of abuse-deterrent properties of PEO-matrix tablets publication-title: AAPS PharmSciTech. doi: 10.1208/s12249-021-02169-6 – volume: 72 start-page: 424 year: 2015 end-page: 30 ident: CR3 article-title: Abuse-deterrent formulations and the prescription opioid abuse epidemic in the United States: lessons learned from OxyContin publication-title: JAMA Psychiatry. doi: 10.1001/jamapsychiatry.2014.3043 – volume: 105 start-page: 418 year: 2017 end-page: 25 ident: CR35 article-title: Changes in mandibular movement during chewing of different hardness foods publication-title: Odontology. doi: 10.1007/s10266-016-0292-z – ident: 2706_CR30 – volume: 109 start-page: 1338 year: 2020 ident: 2706_CR9 publication-title: J Pharm Sci. doi: 10.1016/j.xphs.2019.12.003 – volume: 500 start-page: 255 year: 2016 ident: 2706_CR20 publication-title: Int J Pharm. doi: 10.1016/j.ijpharm.2016.01.031 – volume: 20 start-page: 232 year: 2019 ident: 2706_CR26 publication-title: AAPS PharmSciTech. doi: 10.1208/s12249-019-1452-6 – volume: 21 start-page: 86 year: 2020 ident: 2706_CR49 publication-title: AAPS PharmSciTech. doi: 10.1208/s12249-019-1594-6 – volume: 23 start-page: 1 year: 2009 ident: 2706_CR31 publication-title: Food Hydrocoll. doi: 10.1016/j.foodhyd.2007.11.013 – volume: 21 start-page: 28 year: 2019 ident: 2706_CR48 publication-title: AAPS PharmSciTech. doi: 10.1208/s12249-019-1565-y – ident: 2706_CR19 – volume: 21 start-page: 2 year: 2019 ident: 2706_CR51 publication-title: AAPS PharmSciTech. doi: 10.1208/s12249-019-1528-3 – volume: 3 start-page: 73 year: 2011 ident: 2706_CR6 publication-title: Pharmaceutics. doi: 10.3390/pharmaceutics3010073 – volume: 8 start-page: 117 year: 2002 ident: 2706_CR38 publication-title: Oral Dis. doi: 10.1034/j.1601-0825.2002.02851.x – volume: 35 start-page: 18 year: 2013 ident: 2706_CR43 publication-title: Trends Food Sci Technol. doi: 10.1016/j.tifs.2013.10.005 – volume: 16 start-page: 2142 year: 2015 ident: 2706_CR24 publication-title: Pain Med. doi: 10.1111/pme.12834 – volume: 84 start-page: 104450 year: 2023 ident: 2706_CR16 publication-title: J Drug Deliv Sci Technol. doi: 10.1016/j.jddst.2023.104450 – volume: 561 start-page: 305 year: 2019 ident: 2706_CR29 publication-title: Int J Pharm. doi: 10.1016/j.ijpharm.2019.03.017 – volume: 510 start-page: 57 year: 2016 ident: 2706_CR8 publication-title: Int J Pharm. doi: 10.1016/j.ijpharm.2016.06.012 – volume: 14 start-page: 1977 year: 2021 ident: 2706_CR25 publication-title: Clin Transl Sci. doi: 10.1111/cts.13053 – volume: 66 start-page: 102524 year: 2020 ident: 2706_CR54 publication-title: Innov Food Sci Emerg Technol. doi: 10.1016/j.ifset.2020.102524 – volume: 32 start-page: 554 year: 2018 ident: 2706_CR11 publication-title: Palliat Med. doi: 10.1177/0269216317717192 – volume: 128 start-page: 1015 year: 2018 ident: 2706_CR2 publication-title: Anesthesiology. doi: 10.1097/ALN.0000000000002031 – volume: 9 start-page: 21 year: 2016 ident: 2706_CR55 publication-title: Curr Opin Food Sci. doi: 10.1016/j.cofs.2016.03.006 – volume: 19 start-page: 429 year: 2015 ident: 2706_CR41 publication-title: Clin Oral Invest. doi: 10.1007/s00784-014-1266-6 – volume: 632 start-page: 122557 year: 2023 ident: 2706_CR18 publication-title: Int J Pharm. doi: 10.1016/j.ijpharm.2022.122557 – volume: 72 start-page: 1713 year: 2012 ident: 2706_CR1 publication-title: Drugs. doi: 10.2165/11635860-000000000-00000 – volume: 7 start-page: 1003 year: 2017 ident: 2706_CR23 publication-title: Pain Physician. doi: 10.36076/ppj/2017.7.E1003 – ident: 2706_CR14 – ident: 2706_CR52 – volume: 80 start-page: 295 year: 2010 ident: 2706_CR42 publication-title: Angle Orthod. doi: 10.2319/061109-333.1 – volume: 142 start-page: 41 year: 2002 ident: 2706_CR33 publication-title: Exp Brain Res. doi: 10.1007/s00221-001-0916-5 – volume: 44 start-page: 1885 year: 2018 ident: 2706_CR50 publication-title: Drug Dev Ind Pharm. doi: 10.1080/03639045.2018.1504965 – volume: 626 start-page: 122151 year: 2022 ident: 2706_CR13 publication-title: Int J Pharm. doi: 10.1016/j.ijpharm.2022.122151 – volume: 19 start-page: 1744 year: 2018 ident: 2706_CR22 publication-title: AAPS PharmSciTech. doi: 10.1208/s12249-017-0947-2 – volume: 9 start-page: 671 year: 2012 ident: 2706_CR53 publication-title: Nat methods. doi: 10.1038/nmeth.2089 – volume: 43 start-page: 1667 year: 2010 ident: 2706_CR46 publication-title: J Biomech. doi: 10.1016/j.jbiomech.2010.03.002 – volume: 72 start-page: 424 year: 2015 ident: 2706_CR3 publication-title: JAMA Psychiatry. doi: 10.1001/jamapsychiatry.2014.3043 – volume: 18 start-page: 1278 year: 2017 ident: 2706_CR28 publication-title: Pain Med. doi: 10.1093/pm/pnw208 – volume: 631 start-page: 122486 year: 2023 ident: 2706_CR21 publication-title: Int J Pharm. doi: 10.1016/j.ijpharm.2022.122486 – volume: 14 start-page: 021012 year: 2022 ident: 2706_CR47 publication-title: J Mech Robot. doi: 10.1115/1.4052379 – volume: 5 start-page: 171 year: 2016 ident: 2706_CR10 publication-title: Pain Ther. doi: 10.1007/s40122-016-0062-1 – volume: 38 start-page: 555 year: 2011 ident: 2706_CR34 publication-title: J Oral Rehabil. doi: 10.1111/j.1365-2842.2011.02204.x – volume: 21 start-page: 99 year: 2020 ident: 2706_CR7 publication-title: AAPS PharmSciTech. doi: 10.1208/s12249-020-01646-8 – year: 2023 ident: 2706_CR12 publication-title: J Pharm Innov. doi: 10.1007/s12247-023-09731-8 – volume: 105 start-page: 418 year: 2017 ident: 2706_CR35 publication-title: Odontology. doi: 10.1007/s10266-016-0292-z – volume: 41 start-page: 338 year: 2014 ident: 2706_CR37 publication-title: J Oral Rehabil. doi: 10.1111/joor.12149 – volume: 631 start-page: 122430 year: 2023 ident: 2706_CR15 publication-title: Int J Pharm. doi: 10.1016/j.ijpharm.2022.122430 – volume: 517 start-page: 303 year: 2017 ident: 2706_CR5 publication-title: Int J Pharm. doi: 10.1016/j.ijpharm.2016.12.015 – volume: 23 start-page: 38 year: 2021 ident: 2706_CR4 publication-title: AAPS PharmSciTech. doi: 10.1208/s12249-021-02169-6 – volume: 89 start-page: 39 year: 2006 ident: 2706_CR44 publication-title: Physiol Behav. doi: 10.1016/j.physbeh.2006.05.012 – volume: 51 start-page: 353 year: 2000 ident: 2706_CR40 publication-title: Int J Food Sci Nutr. doi: 10.1080/096374800426948 – volume: 82 start-page: 189 year: 2007 ident: 2706_CR45 publication-title: J Food Eng. doi: 10.1016/j.jfoodeng.2007.02.008 – volume: 38 start-page: 754 year: 2011 ident: 2706_CR36 publication-title: J Oral Rehabil. doi: 10.1111/j.1365-2842.2010.02197.x – volume: 139 start-page: 606 year: 2011 ident: 2706_CR39 publication-title: Am J Orthod Dentofacial Orthop. doi: 10.1016/j.ajodo.2009.07.025 – volume: 43 start-page: 1353 year: 2008 ident: 2706_CR32 publication-title: Mech Mach Theory. doi: 10.1016/j.mechmachtheory.2008.06.003 – volume: 1705 start-page: 464186 year: 2023 ident: 2706_CR17 publication-title: J Chromatogr A. doi: 10.1016/j.chroma.2023.464186 – volume: 569 start-page: 118602 year: 2019 ident: 2706_CR27 publication-title: Int J Pharm. doi: 10.1016/j.ijpharm.2019.118602 |
SSID | ssj0023193 |
Score | 2.3672545 |
Snippet | Abuse-deterrent formulations (ADFs) refer to formulation technologies aiming to deter the abuse of prescription drugs by making the dosage forms difficult to... |
SourceID | proquest pubmed crossref springer |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 245 |
SubjectTerms | Advancements in Modified-release Oral Drug Delivery - Delivery throughout the Gastro-intestinal Tract Biochemistry Biomedical and Life Sciences Biomedicine Biotechnology Delayed-Action Preparations Humans Mastication Pharmacology/Toxicology Pharmacy Polyethylene Glycols Research Article Robotic Surgical Procedures Tablets |
Title | A Chewing Study of Abuse-Deterrent Tablets Containing Polyethylene Oxide Using a Robotic Simulator |
URI | https://link.springer.com/article/10.1208/s12249-023-02706-5 https://www.ncbi.nlm.nih.gov/pubmed/38030835 https://www.proquest.com/docview/2895711896 |
Volume | 24 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1LbxMxELagvXBBvAmFapBQL8TCsdev46q0VCAggkQqJ2sd22qlkkXdRCX_nvE-UqGiShz25oe0n-2ZTzPzDSFvIquY9yxRI42iheGBGrtIVCHbCmihtW97HX7-ok7mxcdTedoXhTVDtvsQkmxf6lYBgZl3TY4BWYo2JscdkQfLu2RXZu6Op3jOyy3NwkMl-vKYf8_72wTd8CtvxERbU3P8gNzvfUQoO1Afkjtx-YgcTDuR6c0YZtc1U80YDmB6LT-9eUx8CYdn8QpXhpwkuIE6QenXTaTvc-pLVmOCWS6YWjWQtam6FhEwrS82EVFDKxTh6-_zEKFNJ4AKvtW-xr3g-_nP3OyrvnxC5sdHs8MT2ndSoAtR6BU1IiZVBKESfiFIbqKvFEfXijObDNfW5NvrpU5FSBWXXqNjUFkZmRUqCvGU7CzrZXxOQGlWFUmbCUusSMWkYiHyoHnSMWhvFyMyGX6uW_Qy47nbxYXLdAMBcR0gDgFxLSBOjsjb7ZxfncjGraNfD5g5vAs5wFEtY71uHJJHqZExWTUizzowt-sJk5V5BM4eD-i6_ro2t2z24v-G75F7uR99Llbk9iXZWV2u4yv0WlZ-n-yWH358OtpvD-sfCgPkiQ |
linkProvider | Springer Nature |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1LbxMxELagHOBS8W54DhLqhVg49vp1jApVgLZEkEi9WevYFpVKtuomgvx7xvtIhYoqcdibx5b283hmNDPfEPI2spJ5zxI10ihaGB6osYtEFUZbAS209s2sw-MTNZkXn0_ladcUVvfV7n1KsnmpGwYEZt7XOQdkKdqYnHfEOFjeJnfQGTC5kGvOx9swCy-V6Npj_i33twm65ldey4k2pubwPtntfEQYt6A-ILfi8iHZn7Yk05shzK56puoh7MP0in5684j4MRz8iL9wZ8hFghuoEoz9uo70Qy59yWxMMMsNU6saMjdVOyICptX5JiJqaIUifP19FiI05QRQwrfKV3gWfD_7mYd9VZePyfzw4-xgQrtJCnQhCr2iRsSkiiBUwi8EyU30peLoWnFmk-Hamqy9XupUhFRy6TU6BqWVkVmhohBPyM6yWsY9AkqzskjajFhiRSpGJQuRB82TjkF7uxiQUf9z3aKjGc_TLs5dDjcQENcC4hAQ1wDi5IC828pctCQbN65-02PmUBdygqNcxmpdOwwepcaIyaoBedqCud1PmMzMI1B62KPrOnWtbzjs2f8tf03uTmbHR-7o08mX5-Renk2fGxe5fUF2Vpfr-BI9mJV_1VzYP8iR5eg |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3dSxwxEA-thdKXUu2H19aagvjSC-aSzdfjoT3UVj3aO_AtbC4JCror7h7t_fed7O6dFovQh31ZMgnsL7Mzw8z8BqGdQHPqHI1ECy1Jppkn2swikRBtebDQyjWzDk9O5eE0Oz4X5_e6-Jtq92VKsu1pSCxNRb1342PLhkD1XpXyQYaAvUk5SIiJxVP0DH7Hg3Svp2y4CrngDe9aZf4t97c5euBjPsiPNmZn9Aq97PxFPGwBXkdPQrGBdsct4fSijyd3_VNVH-_i8R0V9eI1ckO8fxF-wc44FQwucBnx0M2rQA5SGUxiZsKT1DxVVzjxVLXjIvC4vFoEQBAsUsBnvy99wE1pAc7xj9KVcBb-eXmdBn-Vt2_QdPR1sn9IuqkKZMYzVRPNQ5SZ5zLC471gOrhcMnCzGDVRM2V00mQnVMx8zJlwCpyE3IhADZeB87dorSiLsImwVDTPotIDGmkWs0FOfWBesaiCV87Memiw_Lh21lGOp8kXVzaFHgCIbQGxAIhtALGih76sZG5awo1HV39eYmZBL1KyIy9COa8sBJJCQfRkZA-9a8Fc7cd1YunhIN1foms71a0eOez9_y3fRs_HByP7_ej02wf0Io2pTz2MzHxEa_XtPGyBM1O7T819_QMY4uok |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=A+Chewing+Study+of+Abuse-Deterrent+Tablets+Containing+Polyethylene+Oxide+Using+a+Robotic+Simulator&rft.jtitle=AAPS+PharmSciTech&rft.au=Chen%2C+Bangxiang&rft.au=Zhang%2C+Feng&rft.au=Dhupia%2C+Jaspreet&rft.au=Morgenstern%2C+Marco+P.&rft.date=2023-11-29&rft.issn=1530-9932&rft.eissn=1530-9932&rft.volume=24&rft.issue=8&rft_id=info:doi/10.1208%2Fs12249-023-02706-5&rft.externalDBID=n%2Fa&rft.externalDocID=10_1208_s12249_023_02706_5 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1530-9932&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1530-9932&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1530-9932&client=summon |